BIOGEN INTERNATIONAL GMBH v. AMNEAL PHARMACEUTICALS LLC , No. 21-1078 (Fed. Cir. 2022)
Annotate this Case
Download PDF
Case: 21-1078 Document: 94 Page: 1 Filed: 10/31/2022 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ BIOGEN INTERNATIONAL GMBH, BIOGEN MA INC., Plaintiffs-Appellants v. AMNEAL PHARMACEUTICALS LLC, ALKEM LABORATORIES LTD., HETERO USA INC., CIPLA LIMITED, CIPLA USA INC., HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-III, LUPIN ATLANTIS HOLDINGS SA, MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS INC., PHARMATHEN S.A., PRINSTON PHARMACEUTICAL INC., S&B PHARMA, INC., SANDOZ INC., SHILPA MEDICARE LIMITED, SUN PHARMACEUTICAL INDUSTRIES, INC., SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., TWI PHARMACEUTICALS INC., TWI PHARMACEUTICALS USA, INC., Defendants-Appellees ACCORD HEALTHCARE INC., GRAVITI PHARMACEUTICALS INC., GRAVITI PHARMACEUTICALS PVT. LTD., IMPAX LABORATORIES LLC, MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD., SLAYBACK PHARMA LLC, SLAYBACK PHARMA INDIA LLP, TORRENT PHARMA INC., TORRENT Case: 21-1078 2 Document: 94 Page: 2 Filed: 10/31/2022 BIOGEN INTERNATIONAL GMBH v. AMNEAL PHARMACEUTICALS LLC PHARMACEUTICALS LTD., WINDLAS HEALTHCARE PVT. LTD., Defendants ______________________ 2021-1078, 2021-1084, 2021-1086, 2021-1087, 2021-1088, 2021-1090, 2021-1091, 2021-1092, 2021-1093, 2021-1094, 2021-1095, 2021-1096, 2021-1097, 2021-1098, 2021-1441 ______________________ Appeals from the United States District Court for the District of Delaware in Nos. 1:17-cv-00823-MN, 1:17-cv00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN, 1:17-cv00846-MN, 1:17-cv-00847-MN, 1:17-cv-00850-MN, 1:17-cv00851-MN, 1:17-cv-00853-MN, 1:17-cv-00855-MN, 1:17-cv00856-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv00954-MN, and 1:20-cv-01159-MN, Judge Maryellen Noreika. ______________________ ON MOTION ______________________ ORDER Upon consideration of appellants’ unopposed motion to voluntarily dismiss the above-captioned consolidated appeals pursuant to Federal Rule of Appellate Procedure 42(b) with each party to bear its own costs upon dismissal, IT IS ORDERED THAT: (1) The motion is granted. The above-captioned appeals are dismissed. (2) Any other pending motion is denied as moot. Case: 21-1078 Document: 94 BIOGEN INTERNATIONAL GMBH PHARMACEUTICALS LLC Page: 3 Filed: 10/31/2022 v. AMNEAL (3) Each side shall bear its own costs. FOR THE COURT October 31, 2022 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court ISSUED AS A MANDATE: October 31, 2022 3
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
